Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
about
Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patientsPersonalized medicine in rheumatologyPre-administration of turmeric prevents methotrexate-induced liver toxicity and oxidative stressPharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?Formation of multiple pulmonary nodules during treatment with leflunomideThe Effect of Omega-3 Fatty Acids in Patients With Active Rheumatoid Arthritis Receiving DMARDs Therapy: Double-Blind Randomized Controlled Trial.Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis.Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.Combining Human and Rodent Genetics to Identify New Analgesics.Iopromide- and gadopentetic acid-derived preparates used in MR arthrography may be harmful to chondrocytes.Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.Moving toward personalized medicine in rheumatoid arthritis: SNPs in methotrexate intracellular pathways are associated with methotrexate therapeutic outcome.Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models.Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
P2860
Q21131938-9D3A8A66-E70B-4E63-BAB2-C86977729224Q28077413-54AABE7E-B806-42D8-B0C7-8EAAA749CBA6Q35704644-1A505D04-092F-4432-A47A-80F4E209D91BQ35814091-46455A0A-2CF1-49D3-8828-D242C538BADBQ35971505-6A37ADA4-0CAD-46EF-9183-EAAE7C708233Q37137011-423E8EA2-A0BE-4FDE-9AD8-3D48C4F1F0EEQ37158455-6075134E-73AC-42BA-B64F-4478BD552135Q37683906-07097D0A-027D-40A0-873B-2521A961BA2DQ37725354-AE233FD3-B2C8-49E5-B494-87175F6C7BEBQ38648460-8C26D22C-C1E4-441F-8B0C-6D6574819BA6Q38699127-61751918-3CD7-4868-94C4-99C49F57CE57Q38708437-FDDFB43C-405C-4EB0-86BD-3F375F162C66Q39330126-B99DE355-888F-40A4-B2D6-9D506B051237Q40564193-15A68D98-83E0-4275-AE5E-E3E92E2049C5Q40884573-DDEF5948-6CDC-4523-91BC-A46E1CE7A527Q49527931-5665AFE0-08FF-4B8A-8459-EC5E382FFE6DQ49680083-3859D664-EF3B-4474-964F-747227DCDF65
P2860
Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacogenetics and pharmacog ...... te treatment: the 2013 update.
@en
type
label
Pharmacogenetics and pharmacog ...... te treatment: the 2013 update.
@en
prefLabel
Pharmacogenetics and pharmacog ...... te treatment: the 2013 update.
@en
P2093
P2860
P356
P1433
P1476
Pharmacogenetics and pharmacog ...... te treatment: the 2013 update.
@en
P2093
Fei-Yan Deng
Shu-Feng Lei
Xing-Bo Mo
Ying-Hua Qiu
P2860
P304
P356
10.2217/PGS.14.25
P577
2014-03-01T00:00:00Z